T1	Participants 46 89	patients with ventricular tachyarrhythmias.
T2	Participants 581 713	Patients were randomly assigned to undergo serial testing of the efficacy of the seven antiarrhythmic drugs by one of two strategies
T3	Participants 1035 1058	486 randomized subjects
